What does CUSIP 88165UAB5 represent in this 13F holders report?

CUSIP 88165UAB5 is the security identifier for 88165UAB5 - TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1 used to aggregate holder disclosures.

How many institutions held 88165UAB5 - TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1 in Q4 2016?

No institutional holders were reported for 88165UAB5 - TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1 in Q4 2016; review adjacent reporting periods for trend context.

TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1

CUSIP: 88165UAB5

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class: Debt / NOTE 8.000% 6/1
Total 13F principal: $0
Principal change: -$36,575,000
Total reported market value: $0
Number of holders: 0
Value change: -$2,678,000
Number of sells: 8

Quarterly Holders Quick Answers

What is CUSIP 88165UAB5?
CUSIP 88165UAB5 identifies 88165UAB5 - TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2016

Recent filing periods for CUSIP 88165UAB5:

Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015 Q2 2015

TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1

Q4 2016 13F Holders as of 31 Dec 2016

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1 as of Q4 2016.